T1 Condition 406 423 colorectal cancer
T2 Condition 514 521 colitis
T3 Condition 76 93 colorectal cancer
T4 Intervention 294 310 gastrointestinal
T5 Species 455 459 mice
T6 Intervention 39 65 inflammatory bowel disease
T7 Biomarker 266 272 IRAK-M
T8 Intervention 722 740 epithelial barrier
T9 Level 916 922 T-cell
T10 Biomarker 1070 1076 IRAK-M
T11 Organism 234 240 − mice
T12 Intervention 819 835 gastrointestinal
T13 Organism 638 645 Irak-m−
T14 Organism 958 965 Irak-m−
T15 Organism 341 355 human patients
T16 Intervention 294 324 gastrointestinal immune system
T19 Species 648 652 mice
T20 Organism 208 233 human studies and Irak-m−
T21 Organism 966 972 − mice
T22 Organism 474 481 Irak-m−
T23 Protein 1023 1028 NF-κB
T24 Protein 138 141 TLR
T25 Intervention 819 862 gastrointestinal associated lymphoid tissue
T26 Level 881 891 neutrophil
T27 Gene 984 998 splice variant
T28 Biomarker 357 363 IRAK-M
T29 Disease 156 180 overzealous inflammation
T31 Species 236 240 mice
T32 Gene 482 491 − animals
T34 Organism 646 652 − mice
T35 Condition 526 533 colitis
T36 Intervention 604 620 gastrointestinal
